Michael Fulton

Director at Ablative Solutions

Mike’s experience in healthcare includes over 20 years as a successful early-stage investor and entrepreneur. Prior to joining BioStar, Dr. Fulton was a Managing Director of Hopen Life Science Ventures. Before transitioning to venture capital, he was a medical device and healthcare services entrepreneur, most notably at Lanx, Inc., a device company he co-founded in the spinal implant space. Over a span of eight years as CEO of Lanx, he scaled the company from a business plan into an $85 million revenue, a 225-employee corporation that was ultimately acquired by Biomet. He is an inventor of multiple neurosurgical and spinal devices, with over 50 granted the U.S. and international patents. Dr. Fulton received his B.A. from Northwestern University and his M.D. from Cornell University Medical College. He also completed two years of neurosurgery training at the Cleveland Clinic.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Ablative Solutions

Ablative Solutions is a clinical-stage medical device start-up that is pioneering the novel approach of Transcatheter Perivascular Alcohol Denervation for the treatment of hypertension.


Industries

Employees

11-50

Links